Psyence Group Inc. (CSE:PSYG)

Market Cap	1.88M
Revenue (ttm)	n/a
Net Income (ttm)	-16.37M
Shares Out	15.64M
EPS (ttm)	-1.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	4,653
Open	0.1200
Previous Close	0.1200
Day's Range	0.1200 - 0.1200
52-Week Range	0.1050 - 0.3750
Beta	1.24
RSI	44.76
Earnings Date	Nov 28, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, c...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PSYG